Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anja Schrewe is active.

Publication


Featured researches published by Anja Schrewe.


Cell | 2009

A Humanized Version of Foxp2 Affects Cortico-Basal Ganglia Circuits in Mice

Wolfgang Enard; Sabine Gehre; Kurt Hammerschmidt; Sabine M. Hölter; Torsten Blass; Martina K. Brückner; Christiane Schreiweis; Christine Winter; Reinhard Sohr; Lore Becker; Victor Wiebe; Birgit Nickel; Thomas Giger; Uwe Müller; Matthias Groszer; Thure Adler; Antonio Aguilar; Ines Bolle; Julia Calzada-Wack; Claudia Dalke; Nicole Ehrhardt; Jack Favor; Helmut Fuchs; Valérie Gailus-Durner; Wolfgang Hans; Gabriele Hölzlwimmer; Anahita Javaheri; Svetoslav Kalaydjiev; Magdalena Kallnik; Eva Kling

It has been proposed that two amino acid substitutions in the transcription factor FOXP2 have been positively selected during human evolution due to effects on aspects of speech and language. Here, we introduce these substitutions into the endogenous Foxp2 gene of mice. Although these mice are generally healthy, they have qualitatively different ultrasonic vocalizations, decreased exploratory behavior and decreased dopamine concentrations in the brain suggesting that the humanized Foxp2 allele affects basal ganglia. In the striatum, a part of the basal ganglia affected in humans with a speech deficit due to a nonfunctional FOXP2 allele, we find that medium spiny neurons have increased dendrite lengths and increased synaptic plasticity. Since mice carrying one nonfunctional Foxp2 allele show opposite effects, this suggests that alterations in cortico-basal ganglia circuits might have been important for the evolution of speech and language in humans.


PLOS Biology | 2010

Post-Stroke Inhibition of Induced NADPH Oxidase Type 4 Prevents Oxidative Stress and Neurodegeneration

Christoph Kleinschnitz; Henrike Grund; Kirstin Wingler; Melanie E. Armitage; Emma S. Jones; Manish Mittal; David Barit; Tobias Schwarz; Christian Geis; Peter Kraft; Konstanze Barthel; Michael K. Schuhmann; Alexander M. Herrmann; Sven G. Meuth; Guido Stoll; Sabine Meurer; Anja Schrewe; Lore Becker; Valérie Gailus-Durner; Helmut Fuchs; Thomas Klopstock; Martin Hrabé de Angelis; Karin Jandeleit-Dahm; Ajay M. Shah; Norbert Weissmann; Harald Schmidt

The identification of NOX4 as a major source of oxidative stress in stroke and demonstration of dramatic protection after stroke in mice by NOX4 deletion or NOX inhibition, opens up new avenues for treatment.


Methods of Molecular Biology | 2009

Systemic First-Line Phenotyping

Valérie Gailus-Durner; Helmut Fuchs; Thure Adler; Antonio Aguilar Pimentel; Lore Becker; Ines Bolle; Julia Calzada-Wack; Claudia Dalke; Nicole Ehrhardt; Barbara Ferwagner; Wolfgang Hans; Sabine M. Hölter; Gabriele Hölzlwimmer; Marion Horsch; Anahita Javaheri; Magdalena Kallnik; Eva Kling; Christoph Lengger; Corinna Mörth; Ilona Mossbrugger; Beatrix Naton; Cornelia Prehn; Oliver Puk; Birgit Rathkolb; Jan Rozman; Anja Schrewe; Frank Thiele; Jerzy Adamski; Bernhard Aigner; Heidrun Behrendt

With the completion of the mouse genome sequence an essential task for biomedical sciences in the twenty-first century will be the generation and functional analysis of mouse models for every gene in the mammalian genome. More than 30,000 mutations in ES cells will be engineered and thousands of mouse disease models will become available over the coming years by the collaborative effort of the International Mouse Knockout Consortium. In order to realize the full value of the mouse models proper characterization, archiving and dissemination of mouse disease models to the research community have to be performed. Phenotyping centers (mouse clinics) provide the necessary capacity, broad expertise, equipment, and infrastructure to carry out large-scale systemic first-line phenotyping. Using the example of the German Mouse Clinic (GMC) we will introduce the reader to the different aspects of the organization of a mouse clinic and present selected methods used in first-line phenotyping.


Journal of Biological Chemistry | 2011

Requirement of the RNA-editing Enzyme ADAR2 for Normal Physiology in Mice

Marion Horsch; Peter H. Seeburg; Thure Adler; Juan Antonio Aguilar-Pimentel; Lore Becker; Julia Calzada-Wack; Lillian Garrett; Alexander Götz; Wolfgang Hans; Miyoko Higuchi; Sabine M. Hölter; Beatrix Naton; Cornelia Prehn; Oliver Puk; Ildiko Racz; Birgit Rathkolb; Jan Rozman; Anja Schrewe; Jerzy Adamski; Dirk H. Busch; Irene Esposito; Jochen Graw; Boris Ivandic; Martin Klingenspor; Thomas Klopstock; Martin Mempel; Markus Ollert; Holger Schulz; Eckhard Wolf; Wolftgang Wurst

ADAR2, an RNA editing enzyme that converts specific adenosines to inosines in certain pre-mRNAs, often leading to amino acid substitutions in the encoded proteins, is mainly expressed in brain. Of all ADAR2-mediated edits, a single one in the pre-mRNA of the AMPA receptor subunit GluA2 is essential for survival. Hence, early postnatal death of mice lacking ADAR2 is averted when the critical edit is engineered into both GluA2 encoding Gria2 alleles. Adar2−/−/Gria2R/R mice display normal appearance and life span, but the general phenotypic effects of global lack of ADAR2 have remained unexplored. Here we have employed the Adar2−/−/Gria2R/R mouse line, and Gria2R/R mice as controls, to study the phenotypic consequences of loss of all ADAR2-mediated edits except the critical one in GluA2. Our extended phenotypic analysis covering ∼320 parameters identified significant changes related to absence of ADAR2 in behavior, hearing ability, allergy parameters and transcript profiles of brain.


Current Pharmaceutical Biotechnology | 2009

The German mouse clinic: A platform for systemic phenotype analysis of mouse models

Helmut Fuchs; V. Gailus-Durner; Thure Adler; J. A. A. Pimentel; Lore Becker; Ines Bolle; Markus Brielmeier; Julia Calzada-Wack; Claudia Dalke; Nicole Ehrhardt; Nicolas Fasnacht; B. Ferwagner; Ursula Frischmann; Wolfgang Hans; Sabine M. Hölter; Gabriele Hölzlwimmer; Marion Horsch; Anahita Javaheri; Magdalena Kallnik; Eva Kling; Christoph Lengger; Holger Maier; Ilona Mossbrugger; C. Morth; Beatrix Naton; U. Noth; B. Pasche; Cornelia Prehn; Gerhard K. H. Przemeck; Oliver Puk

The German Mouse Clinic (GMC) is a large scale phenotyping center where mouse mutant lines are analyzed in a standardized and comprehensive way. The result is an almost complete picture of the phenotype of a mouse mutant line--a systemic view. At the GMC, expert scientists from various fields of mouse research work in close cooperation with clinicians side by side at one location. The phenotype screens comprise the following areas: allergy, behavior, clinical chemistry, cardiovascular analyses, dysmorphology, bone and cartilage, energy metabolism, eye and vision, host-pathogen interactions, immunology, lung function, molecular phenotyping, neurology, nociception, steroid metabolism, and pathology. The German Mouse Clinic is an open access platform that offers a collaboration-based phenotyping to the scientific community (www.mouseclinic.de). More than 80 mutant lines have been analyzed in a primary screen for 320 parameters, and for 95% of the mutant lines we have found new or additional phenotypes that were not associated with the mouse line before. Our data contributed to the association of mutant mouse lines to the corresponding human disease. In addition, the systemic phenotype analysis accounts for pleiotropic gene functions and refines previous phenotypic characterizations. This is an important basis for the analysis of underlying disease mechanisms. We are currently setting up a platform that will include environmental challenge tests to decipher genome-environmental interactions in the areas nutrition, exercise, air, stress and infection with different standardized experiments. This will help us to identify genetic predispositions as susceptibility factors for environmental influences.


American Journal of Physiology-renal Physiology | 2009

Novel missense mutation of uromodulin in mice causes renal dysfunction with alterations in urea handling, energy, and bone metabolism.

Elisabeth Kemter; Birgit Rathkolb; Jan Rozman; Wolfgang Hans; Anja Schrewe; Christina Landbrecht; Matthias Klaften; Boris Ivandic; Helmut Fuchs; Valérie Gailus-Durner; Martin Klingenspor; Martin Hrabé de Angelis; Eckhard Wolf; Ruediger Wanke; Bernhard Aigner

Uromodulin-associated kidney disease is a heritable renal disease in humans caused by mutations in the uromodulin (UMOD) gene. The pathogenesis of the disease is mostly unknown. In this study, we describe a novel chemically induced mutant mouse line termed Umod(A227T) exhibiting impaired renal function. The A227T amino acid exchange may impair uromodulin trafficking, leading to dysfunction of thick ascending limb cells of Henles loop of the kidney. As a consequence, homozygous mutant mice display azotemia, impaired urine concentration ability, reduced fractional excretion of uric acid, and a selective defect in concentrating urea. Osteopenia in mutant mice is presumably a result of chronic hypercalciuria. In addition, body composition, lipid, and energy metabolism are indirectly affected in heterozygous and homozygous mutant Umod(A227T) mice, manifesting in reduced body weight, fat mass, and metabolic rate as well as reduced blood cholesterol, triglycerides, and nonesterified fatty acids. In conclusion, Umod(A227T) might act as a gain-of-toxic-function mutation. Therefore, the Umod(A227T) mouse line provides novel insights into consequences of disturbed uromodulin excretion regarding renal dysfunction as well as bone, energy, and lipid metabolism.


Mammalian Genome | 2012

Innovations in phenotyping of mouse models in the German Mouse Clinic

Helmut Fuchs; Valérie Gailus-Durner; Susanne Neschen; Thure Adler; Luciana Caminha Afonso; Juan Antonio Aguilar-Pimentel; Lore Becker; Alexander Bohla; Julia Calzada-Wack; Christian M. Cohrs; Anna Dewert; Barbara Fridrich; Lillian Garrett; Lisa Glasl; Alexander Götz; Wolfgang Hans; Sabine M. Hölter; Marion Horsch; Anja Hurt; Eva Janas; Melanie Kahle; Martin Kistler; Tanja Klein-Rodewald; Christoph Lengger; Tonia Ludwig; Holger Maier; Susan Marschall; Kateryna Micklich; Gabriele Möller; Beatrix Naton

Under the label of the German Mouse Clinic (GMC), a concept has been developed and implemented that allows the better understanding of human diseases on the pathophysiological and molecular level. This includes better understanding of the crosstalk between different organs, pleiotropy of genes, and the systemic impact of envirotypes and drugs. In the GMC, experts from various fields of mouse genetics and physiology, in close collaboration with clinicians, work side by side under one roof. The GMC is an open-access platform for the scientific community by providing phenotypic analysis in bilateral collaborations (“bottom-up projects”) and as a partner and driver in international large-scale biology projects (“top-down projects”). Furthermore, technology development is a major topic in the GMC. Innovative techniques for primary and secondary screens are developed and implemented into the phenotyping pipelines (e.g., detection of volatile organic compounds, VOCs).


Frontiers in Bioscience | 2008

Sighted C3H mice - a tool for analysing the influence of vision on mouse behaviour?

Sabine M. Hölter; Claudia Dalke; Magdalena Kallnik; Lore Becker; Marion Horsch; Anja Schrewe; Jack Favor; Thomas Klopstock; J. Beckers; Boris Ivandic; V. Gailus-Durner; Helmut Fuchs; M. H. de Angelis; Jochen Graw; Wolfgang Wurst

It is unclear what role vision plays in guiding mouse behaviour, since the mouse eye is of comparably low optical quality, and mice are considered to rely primarily on other senses. All C3H substrains are homozygous for the Pde6b(rd1) mutation and get blind by weaning age. To study the impact of the Pde6b(rd1) mutation on mouse behaviour and physiology, sighted C3H (C3H.Pde6b+) and normal C3H/HeH mice were phenotyped for different aspects. We confirmed retinal degeneration 1 in C3H/HeH mice, and the presence of a morphologically normal retina as well as visual ability in C3H.Pde6b+ mice. However, C3H.Pde6b+ mice showed an abnormal retinal function in the electroretinogram response, indicating that their vision was not normal as expected. C3H.Pde6b+ mice showed reduced latencies for several behaviours without any further alterations in these behaviours in comparison to C3H/HeH mice, suggesting that visual ability, although impaired, enables earlier usage of the behavioural repertoire in a novel environment, but does not lead to increased activity levels. These results emphasize the importance of comprehensive behavioural and physiological phenotyping.


The FASEB Journal | 2012

Cytochrome c oxidase subunit 4 isoform 2-knockout mice show reduced enzyme activity, airway hyporeactivity, and lung pathology

Maik Hüttemann; Icksoo Lee; Xiufeng Gao; Petr Pecina; Alena Pecinova; Jenney Liu; Siddhesh Aras; Natascha Sommer; Thomas H. Sanderson; Monica Tost; Frauke Neff; Juan Antonio Aguilar-Pimentel; Lore Becker; Beatrix Naton; Birgit Rathkolb; Jan Rozman; Jack Favor; Wolfgang Hans; Cornelia Prehn; Oliver Puk; Anja Schrewe; Minxuan Sun; Heinz Höfler; Jerzy Adamski; Raffi Bekeredjian; Jochen Graw; Thure Adler; Dirk H. Busch; Martin Klingenspor; Thomas Klopstock

Cytochrome c oxidase (COX) is the terminal enzyme of the mitochondrial electron transport chain. The purpose of this study was to analyze the function of lung‐specific cytochrome c oxidase subunit 4 isoform 2 (COX4i2) in vitro and in COX4i2‐knockout mice in vivo. COX was isolated from cow lung and liver as control and functionally analyzed. COX4i2‐knockout mice were generated and the effect of the gene knockout was determined, including COX activity, tissue energy levels, noninvasive and invasive lung function, and lung pathology. These studies were complemented by a comprehensive functional screen performed at the German Mouse Clinic (Neuherberg, Germany). We show that isolated cow lung COX containing COX4i2 is about twice as active (88 and 102% increased activity in the presence of allosteric activator ADP and inhibitor ATP, respectively) as liver COX, which lacks COX4i2. In COX4i2‐knockout mice, lung COX activity and cellular ATP levels were significantly reduced (—50 and — 29%, respectively). Knockout mice showed decreased airway responsiveness (60% reduced Penh and 58% reduced airway resistance upon challenge with 25 and 100 mg methacholine, respectively), and they developed a lung pathology deteriorating with age that included the appearance of Charcot‐Leyden crystals. In addition, there was an interesting sex‐specific phenotype, in which the knockout females showed reduced lean mass (—12%), reduced total oxygen consumption rate (—8%), improved glucose tolerance, and reduced grip force (—14%) compared to wild‐type females. Our data suggest that high activity lung COX is a central determinant of airway function and is required for maximal airway responsiveness and healthy lung function. Since airway constriction requires energy, we propose a model in which reduced tissue ATP levels explain protection from airway hyperresponsiveness, i.e., absence of COX4i2 leads to reduced lung COX activity and ATP levels, which results in impaired airway constriction and thus reduced airway responsiveness; long‐term lung pathology develops in the knockout mice due to impairment of energy‐costly lung maintenance processes; and therefore, we propose mitochondrial oxidative phosphorylation as a novel target for the treatment of respiratory diseases, such as asthma.—Hüttemann, M., Lee, I., Gao, X., Pecina, P., Pecinova, A., Liu, J., Aras, S., Sommer, N., Sanderson, T. H., Tost, M., Neff, F., Aguilar‐Pimentel, J. A., Becker, L., Naton, B., Rathkolb, B., Rozman, J., Favor, J., Hans, W., Prehn, C., Puk, O., Schrewe, A., Sun, M., Höfler, H., Adamski, J., Bekeredjian, R., Graw, J., Adler, T., Busch, D. H., Klingenspor, M., Klopstock, T., Ollert, M., Wolf, E., Fuchs, H., Gailus‐Durner, V., Hrabě de Angelis, M., Weissmann, N., Doan, J. W., Bassett, D. J. P., Grossman, L. I. Cytochrome c oxidase subunit 4 isoform 2‐knockout mice show reduced enzyme activity, airway hyporeactivity, and lung pathology. FASEB J. 26, 3916–3930 (2012). www.fasebj.org


PLOS ONE | 2012

Large-Scale Phenotyping of an Accurate Genetic Mouse Model of JNCL Identifies Novel Early Pathology Outside the Central Nervous System

John F. Staropoli; Larissa Haliw; Sunita Biswas; Lillian Garrett; Sabine M. Hölter; Lore Becker; Sergej Skosyrski; Patricia da Silva-Buttkus; Julia Calzada-Wack; Frauke Neff; Birgit Rathkolb; Jan Rozman; Anja Schrewe; Thure Adler; Oliver Puk; Minxuan Sun; Jack Favor; Ildiko Racz; Raffi Bekeredjian; Dirk H. Busch; Jochen Graw; Martin Klingenspor; Thomas Klopstock; Eckhard Wolf; Wolfgang Wurst; Andreas Zimmer; Edith Lopez; Hayat Harati; Eric Hill; Daniela S. Krause

Cln3Δex7/8 mice harbor the most common genetic defect causing juvenile neuronal ceroid lipofuscinosis (JNCL), an autosomal recessive disease involving seizures, visual, motor and cognitive decline, and premature death. Here, to more thoroughly investigate the manifestations of the common JNCL mutation, we performed a broad phenotyping study of Cln3Δex7/8 mice. Homozygous Cln3Δex7/8 mice, congenic on a C57BL/6N background, displayed subtle deficits in sensory and motor tasks at 10–14 weeks of age. Homozygous Cln3Δex7/8 mice also displayed electroretinographic changes reflecting cone function deficits past 5 months of age and a progressive decline of retinal post-receptoral function. Metabolic analysis revealed increases in rectal body temperature and minimum oxygen consumption in 12–13 week old homozygous Cln3Δex7/8mice, which were also seen to a lesser extent in heterozygous Cln3Δex7/8 mice. Heart weight was slightly increased at 20 weeks of age, but no significant differences were observed in cardiac function in young adults. In a comprehensive blood analysis at 15–16 weeks of age, serum ferritin concentrations, mean corpuscular volume of red blood cells (MCV), and reticulocyte counts were reproducibly increased in homozygous Cln3 Δ ex7/8 mice, and male homozygotes had a relative T-cell deficiency, suggesting alterations in hematopoiesis. Finally, consistent with findings in JNCL patients, vacuolated peripheral blood lymphocytes were observed in homozygous Cln3 Δ ex7/8 neonates, and to a greater extent in older animals. Early onset, severe vacuolation in clear cells of the epididymis of male homozygous Cln3 Δ ex7/8 mice was also observed. These data highlight additional organ systems in which to study CLN3 function, and early phenotypes have been established in homozygous Cln3 Δ ex7/8 mice that merit further study for JNCL biomarker development.

Collaboration


Dive into the Anja Schrewe's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jack Favor

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Christoph Lengger

Wellcome Trust Sanger Institute

View shared research outputs
Top Co-Authors

Avatar

Christian M. Cohrs

Dresden University of Technology

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge